Roivant Sciences (ROIV) Asset Utilization Ratio (2021 - 2026)
Roivant Sciences' Asset Utilization Ratio was 0.00 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 69.2% from 0.00 a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
From fiscal Q1 2022 onward, Roivant Sciences has reported Asset Utilization Ratio for 21 quarters.
- Asset Utilization Ratio has now declined for four consecutive fiscal years.
- In earlier fiscal years, Asset Utilization Ratio was 0.00 in FY2025 (-32.6%), 0.01 in FY2024 (-46.3%), 0.01 in FY2023 (-40.7%) and 0.02 in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Asset Utilization Ratio in data going back to fiscal Q1 2022.
- Compared with a year earlier, Asset Utilization Ratio has declined for 12 straight quarters, with an average decline of 46.0% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was fiscal Q1 2023 (growth of 68.5%); the worst was fiscal Q1 2025 (a decline of 75.5%).
- Per Business Quant data, ROIV's Asset Utilization Ratio in the three fiscal quarters before Q1 2027 was 0.00 (Q4 2026), 0.00 (Q3 2026) and 0.00 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Roivant Sciences | 26.38 Bn | 27.07 Bn | 1.16 Mn | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.02 |
API Access
Roivant Sciences Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();